The spectrum of MOG autoantibody-associated demyelinating diseases (Q28293355)

Pathology of demyelinating diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Autoantibody diagnostics in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Antibodies as biological markers for pathophysiological processes in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

MS and the B cell controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

B cells and antibodies in multiple sclerosis pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Characterization and expression of the cDNA coding for the human myelin/oligodendrocyte glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2',3'-cyclic nucleotide 3'-phosphodiesterase in the CNS of adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Frontline: Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Clinicopathological study of a myelin oligodendrocyte glycoprotein-induced demyelinating disease in LEW.1AV1 rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Exacerbated pathology of viral encephalitis in mice with central nervous system-specific autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Acute Disseminated Encephalomyelitis: Current Understanding and Controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Consensus definitions proposed for pediatric multiple sclerosis and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Natural history of multiple sclerosis with childhood onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Revised diagnostic criteria for neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

The Structure and Function of Myelin Oligodendrocyte Glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Antibody responses to EBV and native MOG in pediatric inflammatory demyelinating CNS diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Anti–Myelin Oligodendrocyte Glycoprotein Antibodies in Pediatric Patients With Optic Neuritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.118

A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23797245

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23797245

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membrane

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23797245